Athira Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Athira Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2020 to Q2 2024.
  • Athira Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $933K, a 19.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $933K -$226K -19.5% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $992K -$220K -18.2% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.05M -$214K -16.9% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $1.11M -$481K -30.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.16M -$489K -29.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.21M -$203K -14.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.26M -$197K -13.5% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.59M +$82K +5.45% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.65M +$101K +6.53% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.42M -$11K -0.77% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.46M +$524K +56% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $1.5M +$545K +56.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.55M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $1.43M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $936K Dec 31, 2020 10-K 2022-03-28
Q3 2020 $959K Sep 30, 2020 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.